Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
Sponsored by LEO Pharma
About this trial
Last updated 11 years ago
Study ID
Treatment with Xamiol® Gel
Status
Completed
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 15 years ago
What is this trial about?
This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed
combination of calcipotriol and betamethason dipropionate, shall investigate in daily
routine the efficacy, tolerability and changes in quality-of-life parameters in patients
with scalp psoriasis
What are the participation requirements?
Inclusion Criteria
- Patients with scalp psoriasis if a treatment with Xamiol® gel is planned anyway
Exclusion Criteria
- Contraindications of Xamiol® Gel listed in the German package insert
- Pretreatment with Xamiol® within the last 4 weeks
- Systemic treatment of psoriasis
- UV light therapy